Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Aging|December 26, 2021
Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune systemCharlotte Liisborg, Vibe Skov, Lasse Kjær, et al.Mathematical Biosciences|May 23, 2020
Global dynamics of healthy and cancer cells competing in the hematopoietic systemMorten Andersen, Hans C Hasselbalch, Lasse Kjær, et al.Plos One|June 16, 2022
Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancersCharlotte Liisborg, Vibe Skov, Lasse Kjær, et al.Eclinicalmedicine|February 7, 2022
Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammationCharlotte Liisborg, Vibe Skov, Lasse Kjær, et al.Journal of Neuroinflammation|August 25, 2020
Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectivesHans C Hasselbalch, Vibe Skov, Lasse Kjær, et al.Plos One|March 10, 2012
A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burdenLasse Kjær, Maj Westman, Caroline Hasselbalch Riley, et al.Scientific Reports|March 11, 2023
Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasmsKathrine Gotfredsen, Charlotte Liisborg, Vibe Skov, et al.Ugeskrift for Laeger|June 26, 2020
[Rationales for using JAK 1/2 inhibitors in severely afflicted patients with COVID-19 pneumonia]Hans Carl Hasselbalch, Anne Poulsen, Vibe Skov, et al.Mathematical Biosciences and Engineering : MBE|December 31, 2020
Dynamics of competing heterogeneous clones in blood cancers explains multiple observations - a mathematical modeling approachKatrine O Bangsgaard, Morten Andersen, Vibe Skov, et al.Pageof 6